Year: 2023
Type: article
Abstract: Kenneth D. R. Setchell discloses equity in Asklepion Pharmaceuticala and is a consultant to Travere Therapeutics and Mirum Pharmaceuticals. The other authors have no competing financial interests. The data from this study (anonymized results) are available from the corresponding author upon request. Figure S1. Blood smear, complete blood count with red blood cell indices, platelet count and mean platelet volume, and histograms depicting the RBC hemoglobin concentration and cell volume evaluated in an Advia instrument from the patient before (upper panel) and >8 months after treatment with reduced plant sterol and cholesterol diet and ezetimibe (lower panel). Although occasional stomatocytes were observed in the post-treatment blood smear, they were significantly reduced in number compared to the pre-treatment sample. Post-treatment MCV was decreased and the absolute reticulocyte count was normalized. The platelet count increased and the mean platelet volume decreased, although not to normal values. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Source: American Journal of Hematology
DOI: 10.1002/ajh.26916
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4361191017